Probiotics and prebiotics in human health: An overview

Bioactive Foods in Promoting Health

Volumn , Issue , 2010, Pages 73-93

  Brunser, Oscar ^a   Gotteland, Martin ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884427417     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374938-3.00006-2     Document Type: Chapter

References (132)

1. MetchnikoffY. The prolongation of life 1908, Optimistic studies, William Heinemann, London.
2. Mitsuoka T. Bifidobacteria and their role in human health. Journal of Industrial Microbiology & Biotechnology 1990, 6:263-268.
3. Tannock G.W. Probiotics: Time for a dose of realism. Current Issues in Intestinal Microbiology 2003, 4:33-42.
4. Brunser O., Gotteland M., Cruchet S., et al. Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatric Research 2006, 59:451-456.
5. Parker R.B. Probiotics, the other half of the antibiotic story. Animal Nutrition Health 1974, 29:4-8.
6. Fuller R. Probiotics in man and animals. The Journal of Applied Bacteriology 1989, 66:365-378.
7. Saavedra J.M., Abi-Hanna A., Moore N., Yolken R.H. Long-term consumption of infant formulas containing live probiotic bacteria: Tolerance and safety. The American Journal of Clinical Nutrition 2004, 79:261-267.
8. Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Foods 2001, Joint FAO/WHO, WHO, Geneva.
9. Wilson M. Manipulation of the indigenous microbiota. Microbial inhabitants of humans. Their ecology and role in health and disease 2005, 395-419. Cambridge University Press, Cambridge. M. Wilson (Ed.).
10. Sanders M.E. Probiotics: Definition, sources, selection, and uses. Clinical Infectious Diseases 2008, 46(Suppl. 2):S58-S61.
11. Brunser O., Gotteland M., Cruchet S. Functional fermented milk products. Issues in complementary feeding. Nestlé Nutrition Workshop Series 2007, Vol. 60:215-250. Nestec Ltd, Vevey; S. Karger AG, Basel. C. Agostoni, O. Brunser (Eds.).
12. Connoly E. Abrahamsson Th, Björkstén B. Safety of D(-) lactic acid producing bacteria in the human infant. Journal of Pediatric Gastroenterology and Nutrition 2005, 41:489-492.
13. Haschke-Becher E., Brunser O., Cruchet S., et al. Urinary D-lactate excretion in infants receiving Lactobacillus johnsonii (La1) with formula. Annals of Nutrition & Metabolism 2008, 53:240-244.
14. Land M.H., Rouster-Stevens K., Woods C.R., et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005, 115:178-181.
15. Snydman D.R. The safety of probiotics. Clinical Infectious Diseases 2008, 46:S11-S104.
16. Hord N.G. Eukariotic-microbiotic crosstalk: Potential mechanisms for health benefits of prebiotics and probiotics. Annual Review of Nutrition 2008, 28:215-231.
17. Besselink M.G., van Santvoort H.C., Buskens E., et al. Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 2008, 371:651-659.
18. Reid G., Gibson G., Guarner F., Versalovic J. Probiotic prophylaxis in predicted severe acute pancreatitis. Lancet 2008, 372:112-113.
19. Reddy B.S., McFie J. Probiotic prophylaxis in predicted severe acute pancreatitis. Lancet 2008, 372:113.
20. Marteau Ph. Probiotic prophylaxis in predicted severe acute pancreatitis. Lancet 2008, 372:114-115.
21. Bengmark S. Is probiotic prophylaxis worthwhile in patients with predicted severe acute pancreatitis?. Nature Clinical Practice. Gastroenterology & Hepatology 2008, 5:602-603.
22. Araya M., Figueroa G., Espinoza J., et al. Acute diarrhoeal disease in children under 7 years of age living in a periurban slum in Santiago, Chile. The Journal of Hygiene (Cambridge) 1985, 95:457-467.
23. Espinoza J., Araya M., Figueroa G., et al. Diarrea aguda en población infantil marginal de Santiago. Salud, mortalidad infantil y perinatal en América Latina 1989, 207-223. La Técnica Impresora, Buenos Aires. International Development Research Centre, Ottawa. A.E. Lattes, M. Farren, J. MacDonald (Eds.).
24. Clements M.L., Levine M.M., Ristaino P.A., et al. Exogenous lactobacilli fed to man-their fate and ability to prevent diarrheal disease. Progress in Food & Nutrition Science 1983, 7:29-37.
25. Brunser O., Araya M., Espinoza J., et al. Effect of an acidified milk on diarrhoea and the carrier state in infants of low socio-economic stratum. Acta Paediatrica Scandinavica 1989, 78:259-264.
26. Isolauri E., Juntunen M., Rautanen T., et al. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991, 88:90-97.
27. Majamaa H., Isolauri E., Saxelin M., Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. Journal of Pediatric Gastroenterology and Nutrition 1995, 20:333-338.
28. Shornikova A.V., Isolauri E., Burkanova L., et al. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of diarrhea. Acta Paediatrica 1997, 86:460-465.
29. Weizman Z., Asli G., Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Pediatrics 2005, 115:5-9.
30. Szajewska H., Setty M., Mrukowicz J., Guandalini S. Probiotics in gastrointestinal diseases in children: Hard and not-so-hard evidence of efficacy. Journal of Pediatric Gastroenterology and Nutrition 2006, 42:454-475.
31. Bartlett J.G. Antibiotic-associated diarrhea. The New England Journal of Medicine 2002, 346:334-339.
32. Zollner-Schwetz I., Högenauer C., Joainig M., et al. Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clinical Infectious Diseases 2008, 47:74-78.
33. Wiström J., Norrby S.R., Myhre E.B., et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated patients: A prospective study. The Journal of Antimicrobial Chemotherapy 2001, 47:43-50.
34. Jaber M.R., Olafsson S., Fung W.L., Reeves M.E. Clinical review of the management of fulminant Clostridium difficile infection. The American Journal of Gastroenterology 2008, 103:195-203.
35. Arvola T., Laiho K., Torkkeli S., et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatric Research 1999, 104:e-64.
36. Szymański H., Armańska M., Kowalska-Duplaga K., Szajewska H. Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: A randomized controlled pilot trial. Digestion 2008, 78:13-17.
37. Buts J.P., Corthier G., Delmee M. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. Journal of Pediatric Gastroenterology and Nutrition 1993, 16:419-425.
38. Eng S., Surawicz C. Colitis pseudomembranous. Encyclopedia of gastroenterology 2004, 379-381. Academic Press, San Diego. L.R. Johnson (Ed.).
39. Vandenplas Y., Brunser O., Szajewska H. Saccharomyces boulardii in childhood. European Journal of Pediatrics 2009, 168:253-265.
40. Langat A.C., Ogutu E., Kamenwa R., Simiyu D.E. Prevalence of Helicobacter pylori in children less than three years of age in health facilities in Nairobi Province. East African Medical Journal 2006, 83:471-477.
41. Gotteland M., Brunser O., Cruchet S. Systematic review: Are probiotics useful in controlling gastric colonization by Helicobacter pylori?. Alimentary Pharmacology & Therapeutics 2006, 23:1077-1086.
42. Cruchet S., Obregon M.C., Salazar G., et al. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003, 19:716-721.
43. Gotteland M., Andrews M., Toledo M., et al. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition 2008, 24:421-426.
44. Gotteland M., Poliak L., Cruchet S., Brunser O. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Paediatrica 2005, 94:1747-1751.
45. Sakamoto I., Igarashi M., Kimura K., et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. The Journal of Antimicrobial Chemotherapy 2001, 47:709-710.
46. Sýkora J., Valecková K., Amlerová J., et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: A prospective randomized double-blind study. Journal of Clinical Gastroenterology 2005, 39:692-698.
47. Goldman C.G., Barrado D.A., Balcarce N., et al. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 2006, 22:984-988.
48. Martin C.R., Walker W.A. Probiotics: Role in pathophysiology and prevention in necrotizing enterocolitis. Seminars in Perinatology 2008, 32:127-137.
49. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. International Journal of Infectious Diseases 1999, 3:197-202.
50. Dani C., Biadaioli R., Bertini G., et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biology of the Neonate 2002, 82:103-108.
51. Bin-Nun A., Bromiker R., Wilschanski M., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. The Journal of Pediatrics 2005, 147:192-196.
52. Deshpande G., Rao S., Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: A systematic review of randomised controlled trials. Lancet 2007, 369:1614-1620.
53. Lin H.C., Su B.H., Chen A.C., et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005, 115:1-4.
54. Lin H.C., Hsu C.H., Chen H.L., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: A multicenter, randomized, controlled trial. Pediatrics 2008, 122:693-700.
55. Alfaleh, K., & Bassler, D. (2008). Probiotics for prevention of necrotizing enterocolitis in preterm infants CD005496. Cochrane Database of Systematic Reviews, 23 (1).
56. McFarland L.V. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Medicine and Infectious Disease 2007, 5:97-105.
57. Marteau P.R., de Vrese M., Cellier C.J., Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. The American Journal of Clinical Nutrition 2001, 73(Suppl. 2):430S-436S.
58. Briand V., Buffet P., Genty S., et al. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: A randomized, double-blind, controlled study. Clinical Infectious Diseases 2006, 43:1170-1175.
59. Ericsson C.D. Nonantimicrobial agents in the prevention and treatment of traveler's diarrhea. Clinical Infectious Diseases 2005, 41(Suppl. 8):S557-S563.
60. Grüber C., Wendt M., Sulser C., et al. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 2007, 62:1270-1276.
61. Sepp E., Julge K., Mikelsaar M., Bjorksten B. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clinical and Experimental Allergy 2005, 35:1141-1146.
62. He F., Ouwehand A.C., Isolauri E., et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunology and Medical Microbiology 2001, 30:43-47.
63. He F., Morita H., Ouwehand A.C., et al. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiology and Immunology 2002, 46:781-785.
64. Isolauri E., Arvola T., Sutas Y., et al. Probiotics in the management of atopic eczema. Clinical and Experimental Allergy 2000, 30:1604-1610.
65. Kalliomaki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease: A randomized placebo-controlled trial. Lancet 2001, 357:1076-1079.
66. Rautava S., Kalliomaki M., Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. The Journal of Allergy and Clinical Immunology 2002, 109:119-121.
67. Kalliomaki M., Salminen S., Poussa T., Isolauri E. Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. The Journal of Allergy and Clinical Immunology 2007, 119:1019-1021.
68. Viljanen M., Kuitunen M., Haahtela T., et al. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatric Allergy and Immunology 2005, 16:65-71.
69. Brouwer M.L., Wolt-Plompen S.A., Dubois A.E., et al. No effects of probiotics on atopic dermatitis in infancy: A randomized placebo-controlled trial. Clinical and Experimental Allergy 2006, 36:899-906.
70. Cremonini F., Talley N.J. Irritable bowel syndrome: Epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterology clinics of North America 2005, 34:189-204.
71. Saito Y.A., Cremonini F., Talley N.J. Association of the 1438G/A and 102T/C polymorphism of the 5-HT2A receptor gene with irritable bowel syndrome 5-HT2A gene polymorphism in irritable bowel syndrome. Journal of Clinical Gastroenterology 2004, 38:561-566.
72. Spiller R.C. Role of infection in irritable bowel syndrome. Journal of Gastroenterology 2007, 42(Suppl. 17):41-47.
73. O'Mahony L., McCarthy J., Kelly P., et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-551.
74. Hanson L.Å., Yolken R.H. Probiotics, other nutritional factors, and intestinal microflora. Nestlé Nutrition Workshop Series 1997, Vol. 42. Nestec Ltd, Vevey/Lippincot-Raven Publishers, Philadelphia.
75. Rousseaux C., Thuru X., Gelot A., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine 2007, 13:35-37.
76. Kajander K., Krogius-Kurikka L., Rinttilä T., et al. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2007, 26:463-473.
77. Kajander K., Myllyluoma E., Rajili-Stojanovi M., et al. Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary Pharmacology & Therapeutics 2008, 27:48-57.
78. Mow W.S., Abreu M.T. Crohn's disease. Encyclopedia of gastroenterology 2004, Vol. I:509-520. Academic Press, San Diego. L.R. Johnson (Ed.).
79. Langmead L., Rampton D.S. Colitis, ulcerative. Encyclopedia of gastroenterology 2004, Vol. I:385-399. Elsevier/Academic Press, San Diego. L.R. Johnson (Ed.).
80. Kozuch P.L., Hanauer S.B. Treatment of inflammatory bowel disease: A review of medical therapy. World Journal of Gastroenterology 2008, 14:354-377.
81. Damaskos D., Kolios G. Probiotics and prebiotics in inflammatory bowel disease: Microflora 'on the scope'. British Journal of Clinical Pharmacology 2008, 65:453-467.
82. Fedorak R.N. Understanding why probiotic therapies can be effective in treating IBD. Journal of Clinical Gastroenterology 2008, 42(Suppl 3 Pt 1):S111-S115.
83. Geier M.S., Butler R.N., Howarth G.S. Inflammatory bowel disease: Current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. International Journal of Food Microbiology 2007, 115:1-11.
84. Rembacken B.J., Snelling A.M., Hawkey P.M, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet 1999, 354:635-639.
85. Henker J., Müller S., Laass M.W., et al. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: An open-label pilot study. Zeitschrift Fur Gastroenterologie 2008, 46:874-875.
86. Ewaschuk J.B., Tejpar Q.Z., Soo I., et al. The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Current Gastroenterology Reports 2006, 8:486-498.
87. Butterworth, A. D., Thomas, A. G., & Akobeng, A. K. (2008). Probiotics for induction of remission in Crohn's disease CD006634. Cochrane Database of Systematic Reviews.
88. Jonkers D., Stockbrügger R. Probiotics in gastrointestinal and liver diseases. Alimentary Pharmacology & Therapeutics 2007, 26(Suppl. 2):133-148.
89. Geier M.S., Butler R.N., Howarth G.S. Probiotics, prebiotics and synbiotics: A role in chemoprevention for colorectal cancer?. Cancer Biology & Therapy 2006, 5:1265-1269.
90. Fotiadis C.I., Stoidis C.N., Spyropoulos B.G., Zografos E.D. Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World Journal of Gastroenterology 2008, 14:6453-6457.
91. Capurso G., Marignani M., Delle Fave G. Probiotics and the incidence of colorectal cancer: When evidence is not evident. Digestive and Liver Disease 2006, 38(Suppl. 2):S277-S282.
92. Lan A., Lagadic-Gossmann D., Lemaire C., et al. Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis 2007, 12:573-591.
93. de Vrese M., Winkler P., Rautenberg P., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: A double blind, randomized, controlled trial. Clinical Nutrition 2005, 24:481-491.
94. Pregliasco F., Anselmi G., Fonte L., et al. A new chance of preventing winter diseases by the administration of symbiotic formulations. Journal of Clinical Gastroenterology 2008, 42(Suppl. 3 Pt 2):S224-S233.
95. Naito S., Koga H., Yamaguchi A., et al. Prevention of recurrence with epirubicin and Lactobacillus casei after transurethral resection of bladder cancer. Journal D'urologie 2008, 179:485-490.
96. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. The Journal of Nutrition 1995, 125:1401-1412.
97. Piñeiro M., Asp N.G., Reid G., et al. FAO Technical meeting on prebiotics. Journal of Clinical Gastroenterology 2008, 42(Suppl. 3 Pt 2):S156-S159.
98. Singhal A., Macfarlane G., Macfarlane S., et al. Dietary nucleotides and fecal microbiota in formula-fed infants: A randomized controlled trial. The American Journal of Clinical Nutrition 2008, 87:1785-1792.
99. Brück W.M., Redgrave M., Tuohy K.M., et al. Effects of bovine alpha-lactalbumin and casein glycomacropeptide-enriched infant formulae on faecal microbiota in healthy term infants. Journal of Pediatric Gastroenterology and Nutrition 2006, 43:673-679.
100. Kunz C., RudloffS., Baier W., et al. Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Annual Review of Nutrition 2000, 20:699-722.
101. Miller J.B. Human milk oligosaccharides: 130 reasons to breast feed. The British Journal of Nutrition 1999, 82:333-335.
102. German J.B., Freeman S.L., Lebrilla C.B., Mills D.A. Human milk oligosaccharides: Evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutrition Workshop Series. Paediatric Programme 2008, 62:205-218.
103. Morrow A.L., Ruiz-Palacios G.M., Jiang X., Newburg D.S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. The Journal of Nutrition 2005, 135:1304-1307.
104. Vijn I., Smeekens S. Fructan: More than a reserve carbohydrate?. Plant Physiology 1999, 120:351-360.
105. Kolida S., Gibson G.R. Prebiotic capacity of inulin-type fructans. The Journal of Nutrition 2007, 137:2503S-2506S.
106. Fanaro S., Boehm G., Garssen J., et al. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: A review. Acta Paediatrica Supplement 2005, 94:22-26.
107. Archer B.J., Johnson S.K., Devereux H.M., Baxter A.L. Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men. The British Journal of Nutrition 2004, 91:591-599.
108. Servin A.L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiology Reviews 2004, 28:405-440.
109. Duggan C., Penny M.E., Hibberd P., et al. Oligofructose-supplemented infant cereal: Two randomized, blinded, community-based trials in Peruvian infants. The American Journal of Clinical Nutrition 2003, 77:937-942.
110. Mason J.B., Kim Y. Nutritional strategies in the prevention of colorectal cancer. Current Gastroenterology Reports 1999, 1:341-353.
111. Reddy B.S., Hamid R., Rao C.V. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 1997, 18:1371-1374.
112. McBain A.J., MacFarlane G.T. Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in-vitro human gut bacterial ecosystems. Journal of Medical Microbiology 2001, 50:833-842.
113. Chonan O., Takahashi R., Watanuki M. Role of activity of gastrointestinal microflora in absorption of calcium and magnesium in rats fed beta1-4 linked galactooligosaccharides. Bioscience, Biotechnology, and Biochemistry 2001, 65:1872-1875.
114. Ohta A., Motohashi Y., Sakai K., et al. Dietary fructooligosaccharides increase calcium absorption and levels of mucosal calbindin-D9k in the large intestine of gastrectomized rats. Scandinavian Journal of Gastroenterology 1998, 33:1062-1068.
115. Scholz-Ahrens K.E., Schaafsma G., van den Heuvel E.G., Schrezenmeir J. Effects of prebiotics on mineral metabolism. The American Journal of Clinical Nutrition 2001, 73(Suppl. 2):459S-464S.
116. Holloway L., Moynihan S., Abrams S.A., et al. Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women. The British Journal of Nutrition 2007, 97:365-372.
117. Griffin I.J., Davila P.M., Abrams S.A. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. The British Journal of Nutrition 2002, 87(Suppl. 2):S187-S191.
118. Abrams S.A., Griffin I.J., Hawthorne K.M., Ellis K.J. Effect of prebiotic supplementation and calcium intake on body mass index. The Journal of Pediatrics 2007, 151:293-298.
119. Pereira I., Gibson G.R. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Critical Reviews in Biochemistry and Molecular Biology 2002, 37:259-281.
120. Almirall M., Francesch M., Perez-Vendrell A.M, et al. The differences in intestinal viscosity produced by barley and beta-glucanase alter digesta enzyme activities and ileal nutrient digestibilities more in broiler chicks than in cocks. The Journal of Nutrition 1995, 125:947-955.
121. Delzenne N.M., Daubioul C., Neyrinck A., et al. Inulin and oligofructose modulate lipid metabolism in animals: Review of biochemical events and future prospects. The British Journal of Nutrition 2002, 87(Suppl. 2):S255-S259.
122. Demigné C., Morand C., Levrat M.A., et al. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. The British Journal of Nutrition 1995, 74:209-219.
123. Cani P.D., Dewever C., Delzenne N.M. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. The British Journal of Nutrition 2004, 92:521-526.
124. Cani P.D., Hoste S., Guiot Y., Delzenne N.M. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. The British Journal of Nutrition 2007, 98:32-37.
125. Cani P.D., Neyrinck A.M., Maton N., Delzenne N.M. Oligofructose promotes satiety in rats fed a high-fat diet: Involvement of glucagon-like Peptide-1. Obesity Research 2005, 13:1000-1007.
126. Woodmansey E.J., McMurdo M.E., Macfarlane G.T., Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Applied and Environmental Microbiology 2004, 70:6113-6122.
127. Bouhnik Y., Attar A., Joly F.A., et al. Lactulose ingestion increases faecal bifidobacterial counts: A randomised double-blind study in healthy humans. European Journal of Clinical Nutrition 2004, 58:462-466.
128. Rajala S.A., Salminen S.J., Seppänen J.H., Vapaatalo H. Treatment of chronic constipation with lactitol sweetened yoghurt supplemented with guar gum and wheat bran in elderly hospital patients. Comprehensive Gerontology A 1988, 2:83-86.
129. Teuri U., Korpela R. Galacto-oligosaccharides relieve constipation in elderly people. Annals of Nutrition & Metabolism 1998, 42:319-327.
130. Kleesen B., Sykura B., Zunft H.-J., Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity and bowel habit in elderly constipated persons. The American Journal of Clinical Nutrition 1997, 65:1397-1402.
131. Mihatsch W.A., Hoegel J., Pohlandt F. Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Acta Paediatrica 2006, 95:843-848.
132. Bongers M.E., de Lorijn F., Reitsma J.B., et al. The clinical effect of a new infant formula in term infants with constipation: A double-blind, randomized cross-over trial. Nutrition Journal 2007, 11(6):8.